Join us as we go over our top stories from the week: CRO Clinipace Raises $4.2M in Quest for $10M and More Employees as They Continue to Grow. Can PPD’s SiteCoach help Overcome the ‘One and Done’ Challenge with Clinical Investigational Sites? University of Vigo’s HYGIA Study Reveals Taking Blood Pressure Meds at Night can Save a Life. CRO Executives to Share Best Practices on Improving Clinical Trials Diversity. Amgen Invests $2.7 Billion in China’s BeiGene with Plans to Develop 20 Pipeline Drugs. War for Clinical Investigator Site Mind Share as Parexel Launches Collaboration with Society for Clinical Research Sites (SCRS). Intermountain Healthcare Investigators Utilize Wearable Technologies. The First Gene Therapy Clinical Trial in Huntington’s Disease Initiated by uniQure. Google Announces Fitbit Acquisition: Opens the Door to Next Level of Decentralized Clinical Research. Immunotherapy in Colorectal Cancer. Timunity Therapeutics: A Penn Therapeutics Spinoff Raises $75M from Diverse Group of Investors. Clinical Challenge: Thymomas and Thymic Carcinoma. Jackson Laboratory & Microsoft Form AI Partnership to Accelerate Drug Discovery & Development. Could Regimented, Prescribed & Individualized Lifestyle Changes Improve Cognition in People at Risk for Alzheimer’s Disease? Green Valley’s Oligomannate Approved for Alzheimer’s Disease Treatment in China Representing the First AD Approval in Decades. University of Kansas Health System Contributes to the Successful Phase III Cystic Fibrosis Treatment now FDA Approved.
Timestamps Clinical Trials 00.32 Cancer 04.27 AI 05.56 Alzheimers 06.23 Lung Disease 07.12Source: